PLEASE NOTE: Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP).
Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org.
Wed, 04/15/2020 - 13:35
#1
Jeanne Brady PharmD
Offline
Last seen: 3 years 9 months ago
Joined: 03/12/2019 - 13:44
andexanet alfa
we are considering Andexxa for formulary addition with restrictions. what are your experiences with Andexxa, do you have both Kcentra as well and how does your institution select qualified patients? adverse events? cost containment? thanks in advance for any insights.